Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More
Xconomy
JUNE 10, 2016
Plans for new incubators were announced in two different cities. The results give the company confidence it can expand its tests to screen for early cancer in high-risk people who are otherwise healthy. The new prices don’t reflect rebates and discounts. Ed Silverman at STAT reported the analyst note first.
Let's personalize your content